Results 111 to 120 of about 760 (154)

Can we escape from top-priority ESKAPE pathogens? [PDF]

Emerg Microbes Infect
Zeng L, Feng Y, Wang M.
europepmc   +1 more source

Integrative review on Acinetobacter baumannii as a multidrug-resistant pathogen: resistance mechanisms and therapeutic perspectives in the context of nosocomial infections. [PDF]

Rev Soc Bras Med Trop
Lima PHM, Lopes CF, Freire JPC, Feliciano LD, Amorim RCO, Mota ML, Cirqueira FF, Lemos FFB, Pedroso SHSP, Melo FF.   +9 more
europepmc   +1 more source

Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii [PDF]

Antibiotics, 2023
Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) remain a clinical challenge due to limited treatment options. Recently, cefiderocol, a novel siderophore cephalosporin, and sulbactam-durlobactam, a bactericidal β-lactam–β-lactamase inhibitor combination, have been approved by the Food and Drug Administration for the treatment of
Emanuele Durante-Mangoni, Spyros Pournaras, Raffaele Zarrilli   +2 more
exaly   +12 more sources